This study will explore whether methylprednisolone treatment is safe, well-tolerated, and
beneficial in patients that are diagnosed with Friedreich Ataxia (FRDA). The study will also
explore if methylprednisolone has any effects on biomarkers associated with FRDA. All
subjects in the study will receive the same steroid treatment.